MiNK Therapeutics, Inc. 是一家臨床階段生物製藥公司,專注於發現、開發及商業化用於治療癌症及其他免疫介導疾病的同種異體、即用型恆定自然殺手T細胞療法。公司總部位於紐約州紐約市。
財務指標
營業收入
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
營業支出
2026-06-30
$3.18M
2026-03-31
$2.84M
2025-12-31
$3.23M
2025-09-30
$2.94M
淨利潤
2026-06-30
-$3.12M
2026-03-31
-$2.74M
2025-12-31
-$2.6M
2025-09-30
-$2.88M
淨利潤率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
每股收益
2026-06-30
$-0.62
2026-03-31
$-0.57
2025-12-31
$-0.56
2025-09-30
$-0.65
息稅折舊攤銷前利潤
2026-06-30
-$3.18M
2026-03-31
-$2.7M
2025-12-31
-$3.23M
2025-09-30
-$2.84M
有效稅率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
項目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
營業收入
$0
$0
$0
$0
營業支出
$3.18M
$2.84M
$3.23M
$2.94M
淨利潤
-$3.12M
-$2.74M
-$2.6M
-$2.88M
淨利潤率
--
--
--
--
每股收益
$-0.62
$-0.57
$-0.56
$-0.65
息稅折舊攤銷前利潤
-$3.18M
-$2.7M
-$3.23M
-$2.84M
有效稅率
--
--
--
--
常見問題
INKT is the ticker symbol for a publicly traded company listed on a U.S. stock exchange. It represents ownership shares in that business, allowing investors to participate in its financial performance. The specific company name, headquarters, and business focus are available on the INKT stock detail page. Because ticker symbols can be reused or changed, always confirm the current company identity and listing details directly from the latest INKT data displayed here.
The most current INKT stock price is shown on this page, typically with real-time or delayed quotes depending on the data feed. You can also check brokerage platforms, financial news sites, or the exchange where INKT is listed. For the exact latest price, bid-ask spread, and trading volume, refer to the live quote section above, as market prices change throughout the trading day.
INKT stock can be influenced by company-specific news such as earnings reports, product updates, management changes, and strategic announcements. Broader market conditions, sector trends, interest rates, and economic data also play a role. Additionally, investor sentiment, trading volume, and liquidity can amplify price movements. Because these factors interact constantly, the stock's price reflects a mix of fundamental and market-driven forces at any given time.
Valuation typically involves comparing INKT's market price to financial metrics like earnings, revenue, or book value. Common tools include the price-to-earnings (P/E) ratio, price-to-sales (P/S), and price-to-book (P/B) ratios. Investors may also compare these multiples to peers or the company's own historical averages. The actual valuation metrics for INKT are not provided here; check the latest financial data and ratios displayed on this page for current figures.
To buy INKT stock, you need a brokerage account that offers access to U.S. exchanges. Once funded, you can place a market or limit order for INKT shares during regular trading hours or, if supported, in extended sessions. Fractional shares may be available depending on your broker. Before trading, confirm any commissions, fees, and order types. The exact process and available features vary by brokerage platform.
Investing in INKT carries risks such as market volatility, sector-specific downturns, and company-specific challenges like competitive pressure, operational setbacks, or financial underperformance. Liquidity risk may also apply if trading volume is low. Additionally, broader economic factors, interest rate changes, and regulatory developments can affect the stock. These risks can lead to price declines, and the actual risk profile depends on INKT's current financial health and business circumstances.